182 related articles for article (PubMed ID: 8640778)
1. Wide expression of the human erythrocyte glucose transporter Glut1 in human cancers.
Younes M; Lechago LV; Somoano JR; Mosharaf M; Lechago J
Cancer Res; 1996 Mar; 56(5):1164-7. PubMed ID: 8640778
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of the human erythrocyte glucose transporter occurs as a late event in human colorectal carcinogenesis and is associated with an increased incidence of lymph node metastases.
Younes M; Lechago LV; Lechago J
Clin Cancer Res; 1996 Jul; 2(7):1151-4. PubMed ID: 9816281
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical detection of Glut3 in human tumors and normal tissues.
Younes M; Lechago LV; Somoano JR; Mosharaf M; Lechago J
Anticancer Res; 1997; 17(4A):2747-50. PubMed ID: 9252709
[TBL] [Abstract][Full Text] [Related]
4. Expression of the neutral amino acids transporter ASCT1 in esophageal carcinomas.
Younes M; Pathak M; Finnie D; Sifers RN; Liu Y; Schwartz MR
Anticancer Res; 2000; 20(5C):3775-9. PubMed ID: 11268453
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical expression of human erythrocyte glucose transporter and fatty acid synthase in infiltrating breast carcinomas and adjacent typical/atypical hyperplastic or normal breast tissue.
Alò PL; Visca P; Botti C; Galati GM; Sebastiani V; Andreano T; Di Tondo U; Pizer ES
Am J Clin Pathol; 2001 Jul; 116(1):129-34. PubMed ID: 11447743
[TBL] [Abstract][Full Text] [Related]
6. GLUT1 expression in human breast carcinoma: correlation with known prognostic markers.
Younes M; Brown RW; Mody DR; Fernandez L; Laucirica R
Anticancer Res; 1995; 15(6B):2895-8. PubMed ID: 8669885
[TBL] [Abstract][Full Text] [Related]
7. Expression and localization of GLUT1 and GLUT12 in prostate carcinoma.
Chandler JD; Williams ED; Slavin JL; Best JD; Rogers S
Cancer; 2003 Apr; 97(8):2035-42. PubMed ID: 12673735
[TBL] [Abstract][Full Text] [Related]
8. GLUT1 glucose transporter: a highly sensitive marker of malignancy in body cavity effusions.
Burstein DE; Reder I; Weiser K; Tong T; Pritsker A; Haber RS
Mod Pathol; 1998 Apr; 11(4):392-6. PubMed ID: 9578091
[TBL] [Abstract][Full Text] [Related]
9. Differential subcellular distribution of glucose transporters GLUT1-6 and GLUT9 in human cancer: ultrastructural localization of GLUT1 and GLUT5 in breast tumor tissues.
Godoy A; Ulloa V; Rodríguez F; Reinicke K; Yañez AJ; García Mde L; Medina RA; Carrasco M; Barberis S; Castro T; Martínez F; Koch X; Vera JC; Poblete MT; Figueroa CD; Peruzzo B; Pérez F; Nualart F
J Cell Physiol; 2006 Jun; 207(3):614-27. PubMed ID: 16523487
[TBL] [Abstract][Full Text] [Related]
10. GLUT1 mRNA and protein expression in ovarian borderline tumors and cancer.
Rudlowski C; Moser M; Becker AJ; Rath W; Buttner R; Schroder W; Schurmann A
Oncology; 2004; 66(5):404-10. PubMed ID: 15331928
[TBL] [Abstract][Full Text] [Related]
11. Expression of facilitative glucose transporters in gastric tumors.
Noguchi Y; Marat D; Saito A; Yoshikawa T; Doi C; Fukuzawa K; Tsuburaya A; Satoh S; Ito T
Hepatogastroenterology; 1999; 46(28):2683-9. PubMed ID: 10522065
[TBL] [Abstract][Full Text] [Related]
12. Properties of the human erythrocyte glucose transport protein are determined by cellular context.
Levine KB; Robichaud TK; Hamill S; Sultzman LA; Carruthers A
Biochemistry; 2005 Apr; 44(15):5606-16. PubMed ID: 15823019
[TBL] [Abstract][Full Text] [Related]
13. Glut 1 expression in transitional cell carcinoma of the urinary bladder is associated with poor patient survival.
Younes M; Juarez D; Lechago LV; Lerner SP
Anticancer Res; 2001; 21(1B):575-8. PubMed ID: 11299807
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical expression and prognostic significance of FAS and GLUT1 in bladder carcinoma.
Visca P; Sebastiani V; Pizer ES; Botti C; De Carli P; Filippi S; Monaco S; Alo PL
Anticancer Res; 2003; 23(1A):335-9. PubMed ID: 12680233
[TBL] [Abstract][Full Text] [Related]
15. Interictal seizure resections show two configurations of endothelial Glut1 glucose transporter in the human blood-brain barrier.
Cornford EM; Hyman S; Cornford ME; Landaw EM; Delgado-Escueta AV
J Cereb Blood Flow Metab; 1998 Jan; 18(1):26-42. PubMed ID: 9428303
[TBL] [Abstract][Full Text] [Related]
16. GLUT1 messenger RNA and protein induction relates to the malignant transformation of cervical cancer.
Rudlowski C; Becker AJ; Schroder W; Rath W; Büttner R; Moser M
Am J Clin Pathol; 2003 Nov; 120(5):691-8. PubMed ID: 14608894
[TBL] [Abstract][Full Text] [Related]
17. Expression of the GLUT1 glucose transporter in gallbladder carcinomas.
Kim YW; Park YK; Yoon TY; Lee SM
Hepatogastroenterology; 2002; 49(46):907-11. PubMed ID: 12143238
[TBL] [Abstract][Full Text] [Related]
18. Human erythrocyte sugar transport is incompatible with available carrier models.
Cloherty EK; Heard KS; Carruthers A
Biochemistry; 1996 Aug; 35(32):10411-21. PubMed ID: 8756697
[TBL] [Abstract][Full Text] [Related]
19. Glucose transporter plasticity during memory processing.
Choeiri C; Staines W; Miki T; Seino S; Messier C
Neuroscience; 2005; 130(3):591-600. PubMed ID: 15590143
[TBL] [Abstract][Full Text] [Related]
20. Glucose-induced activation of glucose uptake in cells from the inner and outer blood-retinal barrier.
Busik JV; Olson LK; Grant MB; Henry DN
Invest Ophthalmol Vis Sci; 2002 Jul; 43(7):2356-63. PubMed ID: 12091438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
